Cystitis-Induced Plasticity of Micturitin Reflexes
膀胱炎引起的尿素反射可塑性
基本信息
- 批准号:8642172
- 负责人:
- 金额:$ 47.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-07-29 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffectAfferent PathwaysAgonistAntibodiesBehaviorBiochemicalBladderC FiberCellsChronicClinical TrialsConfocal MicroscopyConsciousCystitisCytokeratinDyesEconomic BurdenEnrollmentEsthesiaExhibitsFamily memberFiberFrequenciesFundingGrantGrowth Factor OverexpressionHypersensitivityImmunohistochemistryIn Situ HybridizationIncreased frequency of micturitionInflammatoryInositolInterstitial CystitisIon ChannelLabelLifeLimb structureMeasurementMediatingMediator of activation proteinMethodologyMicturition ReflexMolecularMonoclonal AntibodiesMusNerve Growth FactorsNeuropeptidesPACAPR-1 proteinPainPain DisorderPathway interactionsPatientsPelvic PainPelvisPerceptionPeripheral NervesPhospholipase CPolymerase Chain ReactionPreparationProductionProteinsQuality of lifeReflex actionResearch ProposalsRouteSecondary toSensorySensory PhysiologySignal TransductionSpecificitySpinal GangliaSymptomsSyndromeTestingTherapeuticTimeTissuesTranscriptTransducersTransgenic MiceUPK2 geneUp-RegulationUrinationUrothelial CellUrotheliumVisceralWestern BlottingWorkbasechronic painchronic pelvic paindesignimprovedinsect maxadilan proteininsightinterdisciplinary approachintravesicalirritationmouse modelneurochemistryneurofilament protein Hnoveloverexpressionpatch clampperipherinpituitary adenylate cyclase activating polypeptidepituitary adenylate cyclase-activating peptide receptorpressurepromoterpublic health relevancereceptorresearch studyresponsetripolyphosphateurinaryurinary bladder hyperreflexia
项目摘要
DESCRIPTION (provided by applicant): Bladder pain syndrome (BPS)/interstitial cystitis (IC) is a chronic pain syndrome characterized by pain, pressure or discomfort perceived to be bladder related with at least one urinary symptom. The impact of BPS/IC on quality of life and economic burden are enormous. Over the life of this grant, we have hypothesized that pain associated with BPS/IC involves an alteration of visceral sensation/bladder sensory physiology. Changes in visceral sensation may be mediated, in part, by inflammatory changes in the urinary bladder including nerve growth factor (NGF). Monoclonal antibody treatment that specifically inhibits NGF in patients with BPS/IC demonstrates proof of concept; however, clinical trials have halted enrollment due to severe side effects. The need for additional targets beyond NGF is clear. With this competitive renewal application, we propose aims that will provide mechanistic insight into additional NGF-mediated pleiotropic changes that contribute to urinary bladder hyperreflexia and pelvic hypersensitivity in a novel transgenic mouse model of chronic NGF overexpression (NGF-OE) using the urothelium-specific uroplakin II promoter that was characterized during the last funding cycle. The working hypothesis is that increases in urinary frequency and altered sensation that accompany BPS/IC are due to an alteration in the expression, function and interactions of neurochemical mediators and the sensory transducer, transient receptor potential (TRPV) family member TRPV4, in the sensory limb of the urinary bladder reflex. These studies examine the contributions of and interactions between the neuropeptide, PACAP, and receptor PAC1 and TRPV4 to increased voiding frequency and somatic sensitivity in NGF-OE mice. Aim 1: We hypothesize that NGF overexpression exhibited in urothelium and lumbosacral dorsal root ganglia (DRG) of the NGF-OE mouse model induces upregulation of the sensory transducer, TRPV4, in bladder afferent cells in DRG and in urothelial cells of the urinary bladder. We hypothesize that tissue-specific expression of TRPV4, in sensory components (urothelium, DRG) of the micturition reflex contributes to urinary bladder hyperreflexia and pelvic hypersensitivity in NGF-OE mice. Aim 2: We hypothesize that interactions between TRPV4 and PACAP/PAC1 may represent a novel mechanism by which PACAP/PAC1 signaling activates phospholipase C and inositol triphosphate to sensitize TRPV4-mediated changes in voiding behavior and painful sensation. Furthermore, we hypothesize that PAC1 and TRPV4 are co-expressed in bladder afferent DRG and urothelial cells. We will use a multidisciplinary approach including anatomical, biochemical, molecular, electrophysiological, and functional methodologies and a novel ex vivo peripheral nerve recording approach to address these aims. Results will provide key insights into new targets with therapeutic potential to improve urinary bladder function and visceral sensation.
描述(由申请人提供):膀胱疼痛综合征(BPS)/间质性膀胱炎(IC)是一种慢性疼痛综合征,其特征是被认为与膀胱相关的疼痛、压力或不适,并与至少一种泌尿系统症状相关。 BPS/IC 对生活质量和经济负担的影响是巨大的。在这笔资助的整个生命周期中,我们假设与 BPS/IC 相关的疼痛涉及内脏感觉/膀胱感觉生理学的改变。内脏感觉的变化可能部分是由膀胱中的炎症变化(包括神经生长因子(NGF))介导的。特异性抑制 BPS/IC 患者 NGF 的单克隆抗体治疗证明了概念;然而,由于严重的副作用,临床试验已停止招募。显然需要 NGF 之外的其他目标。通过这一竞争性更新申请,我们提出的目标是,使用上一个资助周期中表征的尿路上皮特异性尿斑蛋白 II 启动子,为慢性 NGF 过度表达 (NGF-OE) 的新型转基因小鼠模型中导致膀胱反射亢进和盆腔过敏的额外 NGF 介导的多效性变化提供机制见解。目前的假设是,伴随 BPS/IC 的尿频增加和感觉改变是由于膀胱反射感觉肢中神经化学介质和感觉传感器、瞬时受体电位 (TRPV) 家族成员 TRPV4 的表达、功能和相互作用的改变所致。这些研究考察了神经肽 PACAP 以及受体 PAC1 和 TRPV4 对 NGF-OE 小鼠排尿频率和躯体敏感性增加的贡献和相互作用。目标 1:我们假设 NGF-OE 小鼠模型的尿路上皮和腰骶背根神经节 (DRG) 中表现出的 NGF 过表达会诱导 DRG 中的膀胱传入细胞和膀胱尿路上皮细胞中的感觉传感器 TRPV4 上调。我们假设排尿反射的感觉成分(尿路上皮,DRG)中 TRPV4 的组织特异性表达导致 NGF-OE 小鼠的膀胱反射亢进和盆腔过敏。目标 2:我们假设 TRPV4 和 PACAP/PAC1 之间的相互作用可能代表一种新机制,PACAP/PAC1 信号通过该机制激活磷脂酶 C 和三磷酸肌醇,从而使 TRPV4 介导的排尿行为和疼痛感觉变化变得敏感。此外,我们假设 PAC1 和 TRPV4 在膀胱传入 DRG 和尿路上皮细胞中共表达。我们将使用多学科方法,包括解剖学、生化、分子、电生理学和功能方法以及新颖的离体周围神经记录方法来实现这些目标。结果将为具有改善膀胱功能和内脏感觉的治疗潜力的新靶标提供重要见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET Ann VIZZARD其他文献
MARGARET Ann VIZZARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET Ann VIZZARD', 18)}}的其他基金
Cystitis-induced bladder dysfunction and pain
膀胱炎引起的膀胱功能障碍和疼痛
- 批准号:
10090725 - 财政年份:2021
- 资助金额:
$ 47.07万 - 项目类别:
Cystitis-induced bladder dysfunction and pain
膀胱炎引起的膀胱功能障碍和疼痛
- 批准号:
10545170 - 财政年份:2021
- 资助金额:
$ 47.07万 - 项目类别:
Role of proNGF-p75 signaling in the bladder control after spinal cord injury
proNGF-p75 信号在脊髓损伤后膀胱控制中的作用
- 批准号:
10360573 - 财政年份:2019
- 资助金额:
$ 47.07万 - 项目类别:
Role of proNGF-p75 signaling in the bladder control after spinal cord injury
proNGF-p75 信号在脊髓损伤后膀胱控制中的作用
- 批准号:
10604309 - 财政年份:2019
- 资助金额:
$ 47.07万 - 项目类别:
Cystitis-Induced Plasticity of Micturition Reflexes
膀胱炎引起的排尿反射可塑性
- 批准号:
8011784 - 财政年份:2010
- 资助金额:
$ 47.07万 - 项目类别:
Neurotrophic Mechanisms in LUT Plasticity with Cystitis
膀胱炎 LUT 可塑性的神经营养机制
- 批准号:
7108522 - 财政年份:2003
- 资助金额:
$ 47.07万 - 项目类别:
Neurotrophic Mechanisms in LUT Plasticity with Cystitis
膀胱炎 LUT 可塑性的神经营养机制
- 批准号:
6932294 - 财政年份:2003
- 资助金额:
$ 47.07万 - 项目类别:
Neurotrophic Mechanisms in LUT Plasticity with Cystitis
膀胱炎 LUT 可塑性的神经营养机制
- 批准号:
7278299 - 财政年份:2003
- 资助金额:
$ 47.07万 - 项目类别:
Neurotrophic Mechanisms in LUT Plasticity with Cystitis
膀胱炎 LUT 可塑性的神经营养机制
- 批准号:
6709614 - 财政年份:2003
- 资助金额:
$ 47.07万 - 项目类别:
Neurotrophic Mechanisms in LUT Plasticity with Cystitis
膀胱炎 LUT 可塑性的神经营养机制
- 批准号:
6803515 - 财政年份:2003
- 资助金额:
$ 47.07万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 47.07万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 47.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 47.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 47.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 47.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 47.07万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 47.07万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 47.07万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 47.07万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 47.07万 - 项目类别:
Discovery Grants Program - Individual